GB202004209D0 - New use - Google Patents

New use

Info

Publication number
GB202004209D0
GB202004209D0 GBGB2004209.9A GB202004209A GB202004209D0 GB 202004209 D0 GB202004209 D0 GB 202004209D0 GB 202004209 A GB202004209 A GB 202004209A GB 202004209 D0 GB202004209 D0 GB 202004209D0
Authority
GB
United Kingdom
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2004209.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicore Pharma AB
Original Assignee
Vicore Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vicore Pharma AB filed Critical Vicore Pharma AB
Priority to GBGB2004209.9A priority Critical patent/GB202004209D0/en
Publication of GB202004209D0 publication Critical patent/GB202004209D0/en
Priority to US17/113,416 priority patent/US11123329B1/en
Priority to EP21715306.3A priority patent/EP4125881B1/en
Priority to JP2022557150A priority patent/JP2023520323A/en
Priority to CN202180035480.3A priority patent/CN115605201A/en
Priority to PCT/GB2021/050699 priority patent/WO2021191592A1/en
Priority to CA3176108A priority patent/CA3176108A1/en
Priority to US17/458,886 priority patent/US20210386712A1/en
Priority to US17/580,440 priority patent/US20220233480A1/en
Ceased legal-status Critical Current

Links

GBGB2004209.9A 2020-03-23 2020-03-23 New use Ceased GB202004209D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB2004209.9A GB202004209D0 (en) 2020-03-23 2020-03-23 New use
US17/113,416 US11123329B1 (en) 2020-03-23 2020-12-07 Use of angiotensin II type 2 receptor agonist
EP21715306.3A EP4125881B1 (en) 2020-03-23 2021-03-22 New use of angiotensin ii type 2 receptor agonist
JP2022557150A JP2023520323A (en) 2020-03-23 2021-03-22 Novel use of type 2 angiotensin II receptor agonists
CN202180035480.3A CN115605201A (en) 2020-03-23 2021-03-22 New use of angiotensin II type 2 receptor agonists
PCT/GB2021/050699 WO2021191592A1 (en) 2020-03-23 2021-03-22 New use of angiotensin ii type 2 receptor agonist
CA3176108A CA3176108A1 (en) 2020-03-23 2021-03-22 New use of angiotensin ii type 2 receptor agonist
US17/458,886 US20210386712A1 (en) 2020-03-23 2021-08-27 New use of angiotensin ii type 2 receptor agonist
US17/580,440 US20220233480A1 (en) 2020-03-23 2022-01-20 Use of angiotensin ii type 2 receptor agonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2004209.9A GB202004209D0 (en) 2020-03-23 2020-03-23 New use

Publications (1)

Publication Number Publication Date
GB202004209D0 true GB202004209D0 (en) 2020-05-06

Family

ID=70546597

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2004209.9A Ceased GB202004209D0 (en) 2020-03-23 2020-03-23 New use

Country Status (1)

Country Link
GB (1) GB202004209D0 (en)

Similar Documents

Publication Publication Date Title
CA202905S (en) Half-boot
CA196956S (en) Onesie
GB202005890D0 (en) New uses
GB201807286D0 (en) New use
CA208524S (en) Soundbar
CA199411S (en) Handshower
GB202017367D0 (en) Novel use
CA198107S (en) Protractor-ruler
GB202102147D0 (en) New use
GB202009574D0 (en) New use
GB202006849D0 (en) New use
GB202005057D0 (en) New Use
GB202004209D0 (en) New use
GB202010074D0 (en) Use
GB202006382D0 (en) Use
GB202319559D0 (en) New use
GB202217159D0 (en) New use
GB202201723D0 (en) New use
CA212416S (en) Aéronef
CA212654S (en) Velomobile
CA207516S (en) Smartglasses
CA207517S (en) Smartglasses
CA207518S (en) Smartglasses
CA207519S (en) Smartglasses
CA207311S (en) Handleset

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)